GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eton Pharmaceuticals Inc (NAS:ETON) » Definitions » EPS without NRI

Eton Pharmaceuticals (Eton Pharmaceuticals) EPS without NRI : $0.04 (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Eton Pharmaceuticals EPS without NRI?

Eton Pharmaceuticals's earnings per share without non-recurring items for the three months ended in Mar. 2024 was $-0.03. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was $0.04.

During the past 3 years, the average earnings per share (NRI) Growth Rate was 68.90% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 57.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Eton Pharmaceuticals's EPS without NRI or its related term are showing as below:

ETON' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 29.6   Med: 68.9   Max: 73.4
Current: 68.9

During the past 7 years, Eton Pharmaceuticals's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 73.40% per year. The lowest was 29.60% per year. And the median was 68.90% per year.

ETON's 3-Year EPS without NRI Growth Rate is ranked better than
94.29% of 840 companies
in the Drug Manufacturers industry
Industry Median: 9.6 vs ETON: 68.90

Eton Pharmaceuticals's EPS (Diluted) for the three months ended in Mar. 2024 was $-0.03. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $0.04.

Eton Pharmaceuticals's EPS (Basic) for the three months ended in Mar. 2024 was $-0.03. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was $0.04.


Eton Pharmaceuticals EPS without NRI Historical Data

The historical data trend for Eton Pharmaceuticals's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eton Pharmaceuticals EPS without NRI Chart

Eton Pharmaceuticals Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS without NRI
Get a 7-Day Free Trial -1.03 -1.33 -0.10 -0.36 -0.04

Eton Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.10 0.18 -0.02 -0.09 -0.03

Competitive Comparison of Eton Pharmaceuticals's EPS without NRI

For the Drug Manufacturers - Specialty & Generic subindustry, Eton Pharmaceuticals's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eton Pharmaceuticals's PE Ratio without NRI Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eton Pharmaceuticals's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Eton Pharmaceuticals's PE Ratio without NRI falls into.



Eton Pharmaceuticals EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eton Pharmaceuticals  (NAS:ETON) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Eton Pharmaceuticals EPS without NRI Related Terms

Thank you for viewing the detailed overview of Eton Pharmaceuticals's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Eton Pharmaceuticals (Eton Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
21925 West Field Parkway, Suite 235, Deer Park, IL, USA, 60010-7278
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has a diversified pipeline of around eleven product candidates in various stages of development.
Executives
David Krempa officer: Chief Business Officer 29125 W FIELD PARKWAY, SUITE 235, DEER PARK IL 60010
Sean Brynjelsen director, officer: President & CEO C/O ETON PHARMACEUTICALS, INC., 21925 W FIELD PKWY #235, DEER PARK IL 60010
James R. Gruber officer: Chief Financial Officer 618 AMES STREET, LIBERTYVILLE IL 60048
Opaleye Management Inc. 10 percent owner ONE BOSTON PLACE, SUITE 2600, BOSTON MA 02108
William Wilson Troutman officer: CFO, Treasurer & Secretary 21925 W FIELD PARKWAY, SUITE 235, DEER PARK IL 60010
Imprimis Pharmaceuticals, Inc. 10 percent owner 102 WOODMONT BLVD, SUITE 610, NASHVILLE TN 37215
Jennifer Mckie Adams director 5410 TENNESSEE AVE, NASHVILLE TN 37209
Charles J Casamento director 99 BELBROOK WAY, ATHERTON CA 94027
Norbert G Riedel director BAXTER INTERNATIONAL INC, ONE BAXTER PKWY DF2-1W, DEERFIELD IL 60015
Mark L Baum director C/O IMPRIMIS PHARMACEUTICALS, INC, 12264 EL CAMINO REAL, SUITE 350, SAN DIEGO CA 92130
Paul V Maier director 3595 JOHN HOPKINS COURT, SAN DIEGO CA 92121

Eton Pharmaceuticals (Eton Pharmaceuticals) Headlines

From GuruFocus

Eton Pharmaceuticals Appoints James Gruber as Chief Financial Officer

By GuruFocusNews GuruFocusNews 04-11-2022

Eton Pharmaceuticals Announces Sale of Hospital Products

By GuruFocusNews GuruFocusNews 06-24-2022

Eton Pharmaceuticals to Present at the LD Micro Main Event XV Conference

By Value_Insider Value_Insider 10-18-2022